{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:45:00Z","timestamp":1791809100698,"version":"4.3.4"},"reference-count":18,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Research Council of Svenska Spel. MW","award":["FO2022-0008"],"award-info":[{"award-number":["FO2022-0008"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Australas Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Dopaminergic medications are commonly prescribed for Parkinson\u2019s disease (PD), restless legs syndrome, pituitary and psychotic disorders. Accumulating evidence indicates that dopaminergic treatment triggers impulsive-compulsive behaviors (ICBs), yet systematic synthesis of clinical evidence remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This scoping review summarizes original research directly clinically relevant to ICBs under dopaminergic treatment, selected through systematic searches of MEDLINE PubMed, Web of Science, Embase and PsycInfo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 349 included studies, most focused on PD, with limited evidence from other populations. Reported ICB prevalences ranged between 15 and 35%. ICBs were associated with impaired daily functioning, depression, anxiety and significant family and financial burden. Younger age, male sex and dopamine agonist treatment, especially with pramipexole and ropinirole, were ICB risk factors. Management mainly involved tapering or discontinuing dopamine agonist treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ICBs in PD patients are well characterized, but under-recognition in health care and limited treatment strategies persist. Iatrogenic ICBs in other patient populations remain poorly studied.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10398562261439053","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:13:25Z","timestamp":1774710805000},"page":"432-436","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical aspects of impulsive-compulsive behaviors under dopaminergic treatment\u2014A scoping review"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-0276","authenticated-orcid":false,"given":"Mirjam","family":"Wolfschlag","sequence":"first","affiliation":[{"name":"Lund University"},{"name":"Sk\u00e5ne University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8511-1791","authenticated-orcid":false,"given":"Darya","family":"St\u00e5hl","sequence":"additional","affiliation":[{"name":"Lund University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[{"name":"Lund University"},{"name":"Sk\u00e5ne University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Odin","sequence":"additional","affiliation":[{"name":"Lund University"},{"name":"Sk\u00e5ne University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"e_1_3_5_2_2","unstructured":"Ritter JM Flower RJ Henderson G et al. Rang & Dale\u2019s pharmacology. Elsevier Science."},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30311-9"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18040465"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01087-y"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-117"},{"key":"e_1_3_5_8_2","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius JR","year":"2010","unstructured":"Cornelius JR, Tippmann-Peikert M, Slocumb NL, et al. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010; 33: 81\u201387, 2010\/02\/04.","journal-title":"Sleep"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz076"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001773"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.237019"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.07.007"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.07.604"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/1524838014561269"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10899-015-9582-6"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29700"},{"key":"e_1_3_5_17_2","first-page":"20250402","article-title":"Managing impulse control and related behavioral disorders in Parkinson's disease: where we are in 2025?","volume":"1","author":"Rigon L","year":"2025","unstructured":"Rigon L, Fogliano C, Chaudhuri KR, et al. Managing impulse control and related behavioral disorders in Parkinson's disease: where we are in 2025? Expert Rev Neurother 2025; 1\u201318: 20250402\u201320250554. https:\/\/doi.org\/10.1080\/14737175.2025.2485337","journal-title":"Expert Rev Neurother"},{"key":"e_1_3_5_18_2","unstructured":"Covidence systematic review tool. https:\/\/www.covidence.org\/ (2025 Accessed 31st August 2025)."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"}],"container-title":["Australasian Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10398562261439053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10398562261439053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10398562261439053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:50:27Z","timestamp":1791805827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10398562261439053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/10398562261439053"],"URL":"https:\/\/doi.org\/10.1177\/10398562261439053","relation":{},"ISSN":["1039-8562","1440-1665"],"issn-type":[{"value":"1039-8562","type":"print"},{"value":"1440-1665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}